Cabozantinib S-malate
Spécifications
1140909-48-3Numéro CAS
691-711-0Numéro CE
1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acidNom IUPAC
C32H30FN3O10Formule chimique
635.6 g/molMasse molaire
Cabozantinib S-malate; 1140909-48-3; Cabozantinib malate; cabozantinib (S)-malate; Cabometyx; XL184; DR7ST46X58; CHEBI:72319; DTXSID60915949; RefChem:1080604; DTXCID501510465; Cabozantinib malate (XL184); Cabozantinib (S-malate); Cabozantinib L-Malate Salt; MFCD20923480; Cabozantinib s-malate [USAN]; C32H30FN3O10; 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acid; N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate; Cabometyx (TN); Cometriq (TN); Cabozantinib malate (JAN); Cabozantinib s-malate (USAN); CABOZANTINIB MALATE [JAN]; cabozantinib L-malate; UNII-DR7ST46X58; XL184 (S-malate);BMS-907351 (S-malate); RESNIBEN; XL-184 malate; Cabozantinib S-malate?; Cabozantinib S-Malate salt; XL184(Cabozantinib malate); MLS006010951; orb1226924; orb1307421; CHEMBL2103868; SCHEMBL29350740; SCHEMBL29881226; HFCFMRYTXDINDK-WNQIDUERSA-N; GLXC-10543; EX-A2819; EBC-17171; AKOS025401945; CABOZANTINIB S-MALATE [WHO-DD]; CCG-270301; CS-0201; FC64967; AC-27471; AS-75255; HY-12044; SMR004702755; SY105860; CABOZANTINIB S-MALATE [ORANGE BOOK]; SW218093-2; D10095; F861544; Q27139901; (2S)-2-Hydroxybutanedioic acid--N~1~-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (1/1); (2S)-2-hydroxybutanedioic acid; N'1-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; 1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)- mono((2S)-2-hydroxybutanedioate); Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[4-[(6,7- dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1- cyclopropanedicarboxamide; cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide, (S) malate salt; inverted exclamation mark N-[4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl]-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-Hydroxysuccinate; N-(4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE MONO((2S)-2-HYDROXYBUTANEDIOATE); N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (S)-2-hydroxysuccinate; N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (2S)-2-hydroxybutanedioate; N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide;(2S)-2-hydroxybutanedioic acidSynonymes
Produits contenant Cabozantinib S-malate
카보메틱스정20밀리그램(카보잔티닙)카보메틱스정40밀리그램(카보잔티닙)카보메틱스정60밀리그램(카보잔티닙)CABOMETYX 60 mg, comprimé pelliculéCABOMETYX 40 mg, comprimé pelliculéCABOMETYX 20 mg, comprimé pelliculéCabozantinib Malate; CAS:1140909-48-3Cabozantinib MalateCabozantinib MalateCabometyxCabozantinib Malate1140909-48-3
Page 1 sur 2
Entreprises vendant Cabozantinib S-malate
JM
Jiangsu Magic Biotechnology Co., LtdChinaHD
Hangzhou Dingyan Chem Co., LtdChinaSQ
SICHUAN QINGMU PHARMACEUTICAL CO.,LTD.ChinaSD
SHIJIAZHUANG DINGMIN PHARMACEUTICAL SCIENCES CO., LTDChinaWH
Wuxi Hexia Chemical CompanyChina입센
입센코리아(주)Republic of KoreaBS
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.ChinaV(
VuRoyal (SuQian) Pharmaceutical Company LLCChina